McKesson reported 16 suspicious orders out of 1.6 million. The penalty was $150 million.
It was the company's second settlement for the same failure. The first, in 2008, had required it to build a monitoring system.
McKesson agreed in January 2017 to pay a $150 million civil penalty and suspend controlled-substance sales from distribution centers in Colorado, Ohio, Michigan and Florida.
The history is the story. In 2008 McKesson paid $13.25 million over unreported suspicious orders and promised an effective monitoring system. The government said it then processed 1.6 million controlled-substance orders in Colorado between 2008 and 2013 and flagged 16.
The Justice Department called the suspensions among the most severe sanctions a distributor had ever accepted. In practice they were staggered, which blunted the effect. There were no criminal charges.
The duty at issue is ordinary: report orders of unusual size, frequency or pattern. McKesson failed to do it after paying once and promising to. A second civil penalty, with staggered suspensions and no prosecution, was the regulatory response. Five years later came the $7.4 billion settlement.
Sources
- biopharmadive.com · biopharmadive.com/news/mckesson-settlement-150-doj-dea-opioids/434324/
- keranews.org · keranews.org/2017-01-27/drug-distributors-penalized-for-turning-blind-eye-in-opioid-epidem…
Cite this report
The Precedent. "McKesson reported 16 suspicious orders out of 1.6 million. The penalty was $150 million.." September 2, 2026. https://theprecedent.org/article/mckesson-reported-16-suspicious-orders-out-of-16-million-the-penalty-was-150-mil
